drug · small molecule
palazestrant
Phase 3updated 3mo agoby $OLMA Olema Pharmaceuticals, Inc.🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Phase 1 2 (across all indications), with 2 investigational indications.
all catalysts(0)
nothing on the calendar yet
Trials studying palazestrant
- phase3Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
- phase3OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
- phase1A Phase 1 Study of Oral OP-1250 in Combination With Palbociclib in HR+/HER2- Breast Cancer Patients
- phase1Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer
- phase1Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 50m ago
Found something off?
comments(0)
5-min edit window · permanent after that